UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lung cancer in never smokers: The role of different risk factors other than tobacco smoking

Critical reviews in oncology/hematology, 2020-04, Vol.148, p.102895-102895, Article 102895

2020

Volltextzugriff (PDF)

Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

Critical reviews in oncology/hematology, 2020-07, Vol.151, p.102978-102978, Article 102978

2020

Volltextzugriff (PDF)

Ischemic stroke: A paradoxical manifestation of cancer

Critical reviews in oncology/hematology, 2021-01, Vol.157, p.103181-103181, Article 103181

2021

Volltextzugriff (PDF)

Experimental steady-state and transient thermal performance of materials for thermal energy storage in building applications: From powder SS-PCMs to SS-PCM-based acrylic plaster

Energy (Oxford), 2022-07, Vol.250, p.123768, Article 123768

2022

Volltextzugriff (PDF)

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial

JAMA oncology, 2020-06, Vol.6 (6), p.856

2020

Volltextzugriff (PDF)

Facing an un-met need in lung cancer screening: The never smokers

Critical reviews in oncology/hematology, 2024-10, Vol.202, p.104436, Article 104436

2024

Volltextzugriff (PDF)

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib

PloS one, 2019-06, Vol.14 (6), p.e0217340-e0217340

2019

Volltextzugriff (PDF)

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial

JAMA oncology, 2019-11, Vol.5 (11), p.e192553

2019

Volltextzugriff (PDF)

How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review

Critical reviews in oncology/hematology, 2021-10, Vol.166, p.103459-103459, Article 103459

2021

Volltextzugriff (PDF)

New opportunities in a challenging disease: lurbinectedin for relapsed small-cell lung cancer

The lancet oncology, 2020-05, Vol.21 (5), p.605-607

2020

Volltextzugriff (PDF)

Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients

Oncotarget, 2017-11, Vol.8 (60), p.101994-102005

2017

Volltextzugriff (PDF)

Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study

Lung cancer (Amsterdam, Netherlands), 2019-04, Vol.130, p.67-75

2019

Volltextzugriff (PDF)

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

Frontiers in oncology, 2020-09, Vol.10, p.570233-570233

2020

Volltextzugriff (PDF)

The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments

Lung cancer (Amsterdam, Netherlands), 2018-05, Vol.119, p.7-13

2018

Volltextzugriff (PDF)

Sarcopenia as a Predictive Factor for Carboplatin Toxicity in Patients with Advanced Non-Small Cell Lung Cancer

Nutrition and cancer, 2024-07, p.1-9

2024

Volltextzugriff (PDF)

Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patients

Scientific reports, 2022-02, Vol.12 (1), p.2210-2210, Article 2210

2022

Volltextzugriff (PDF)

EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.265-272

2018

Volltextzugriff (PDF)

Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study

Lung cancer (Amsterdam, Netherlands), 2024-08, Vol.194, p.107864, Article 107864

2024

Volltextzugriff (PDF)

Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question

Pharmaceutics, 2022-06, Vol.14 (6), p.1243

2022

Volltextzugriff (PDF)

Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019–Infected Patients With Lung Cancer

Journal of thoracic oncology, 2020-11, Vol.15 (11), p.1767-1772

2020

Volltextzugriff (PDF)

Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer

BMC cancer, 2016-08, Vol.16 (1), p.633-633, Article 633

2016

Volltextzugriff (PDF)

Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer

Frontiers in oncology, 2023-03, Vol.13, p.1108124

2023

Volltextzugriff (PDF)

Cost-utility analysis of genomic profiling in early breast cancer in Colombia

Cost effectiveness and resource allocation, 2023-07, Vol.21 (1), p.42-42, Article 42

2023

Volltextzugriff (PDF)

Treatment for Advanced Non-Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)

Journal of Immunotherapy and Precision Oncology, 2023-11, Vol.6 (4), p.185-186

2023

Volltextzugriff (PDF)

1 – 25 von 369

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(311)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Lung cancer in never smokers: The role of different risk factors other than tobacco smoking

Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

Ischemic stroke: A paradoxical manifestation of cancer

Experimental steady-state and transient thermal performance of materials for thermal energy storage in building applications: From powder SS-PCMs to SS-PCM-based acrylic plaster

Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial

Facing an un-met need in lung cancer screening: The never smokers

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial

How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review

New opportunities in a challenging disease: lurbinectedin for relapsed small-cell lung cancer

Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients

Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study

Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy

The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments

Sarcopenia as a Predictive Factor for Carboplatin Toxicity in Patients with Advanced Non-Small Cell Lung Cancer

Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patients

EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP)

Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study

Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question

Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019–Infected Patients With Lung Cancer

Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer

Case report: Osimertinib administration during pregnancy in a woman with advanced EGFR-mutant non-small cell lung cancer

Cost-utility analysis of genomic profiling in early breast cancer in Colombia

Treatment for Advanced Non-Small Lung Cancer (NSCLC) with Mutated EGFR in Low- and Middle-Income Countries (LMICs)

Suchergebnisse filtern